Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications
Year: 2021
Type: review
Abstract: Cyanobacteria are photosynthetic prokaryotic organisms which represent a significant source of novel, bioactive, secondary metabolites, and they are also considered an abundant source of bioactive compounds/drugs, such as dolastatin, cryptophycin 1, curacin toyocamycin, phytoalexin, cyanovirin-N and phycocyanin. Some of these compounds have displayed promising results in successful Phase I, II, III and IV clinical trials. Additionally, the cyanobacterial compounds applied to medical research have demonstrated an exciting future with great potential to be developed into new medicines. Most of these compounds have exhibited strong pharmacological activities, including neurotoxicity, cytotoxicity and antiviral activity against HCMV, HSV-1, HHV-6 and HIV-1, so these metabolites could be promising candidates for COVID-19 treatment. Therefore, the effective large-scale production of natural marine products through synthesis is important for resolving the existing issues associated with chemical isolation, including small yields, and may be necessary to better investigate their biological activities. Herein, we highlight the total synthesized and stereochemical determinations of the cyanobacterial bioactive compounds. Furthermore, this review primarily focuses on the biotechnological applications of cyanobacteria, including applications as cosmetics, food supplements, and the nanobiotechnological applications of cyanobacterial bioactive compounds in potential medicinal applications for various human diseases are discussed.
Source: Marine Drugs
DOI: 10.3390/md19050241
Institutions: Stockholm University, Menoufia University, Suez Canal University, Humboldt-Universität zu Berlin, Shiraz University of Medical Sciences, University of the West of Scotland, Dalian Polytechnic University, Zhejiang Chinese Medical University, National Institute of Oceanography and Fisheries, Jinan University, Jiangsu University, Uppsala University
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: cyanobacteria, cyanobacterial secondary metabolites, bioactive compounds, marine natural products, total synthesis, stereochemistry, dolastatin, toyocamycin, phytoalexins, cyanovirin-N, phycocyanin, antiviral activity, HIV-1, COVID-19 treatment, nanobiotechnology, cosmetics, dietary supplements, biotechnology applications
Open Access status: gold
Estimated APC paid: $2,108
Funder: Stockholms Universitet
Award: G7122737829
OpenAlex ID: W3158735209
